Apply for the start-up pitch
Call for poster abstracts
Send us your application to pitch at the AMR Conference
10 ventures will be shortlisted to pitch at the AMR Conference for a chance to win 10,000 Euros.
We are looking for translational projects, startups younger than 5 years and with less than 5 million raised. We are open in this competition to all products and technologies that can help in the fight against AMR. This includes therapeutics, platform technologies, diagnostics, vaccines, digital health tools.
Selected companies will receive one free ticket to the AMR Conference. All applicants are eligible for a discounted ticket.
The deadline for applications for the start-up pitch is 22nd January 2023.
Please click on the button below to submit your 60 seconds pitch video and a pitch deck.
The call for poster abstracts is now open
Scientists from SMEs and academic institutions are invited to submit an abstract for a poster presentation addressing the following topics:
- Traditional and non-traditional therapeutic approaches to tackle AMR in humans and animals
- Diagnostic AMR innovations for humans and animals
- Technologies enabling antimicrobial vaccine and drug development
The abstract text should not be longer than 350 words. A maximum of one picture, graph or table can be included per abstract. All abstracts will be reviewed by a scientific committee. You will be notified about the outcome of your poster application by early February 2023.
The deadline for abstract submission is 22nd January 2023.
Please send your poster abstract for review by clicking on the button below.
Please save the date for the upcoming
7th AMR Conference 2023
taking place 16-17 March at the Congress Center Basel.
About the conference
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, clinics, finance, regulatory affairs and intellectual property.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.